We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

Identification of RNA modification-associated single-nucleotide polymorphisms in genomic loci for low-density lipoprotein cholesterol concentrations

    Fan Tang‡

    Department of Epidemiology, Jiangsu Key Laboratory of Preventive & Translational Medicine for Geriatric Diseases, School of Public Health, Medical College of Soochow University, China

    ‡These authors contributed equally to this work

    Search for more papers by this author

    ,
    Chengcheng Duan‡

    Department of Epidemiology, Jiangsu Key Laboratory of Preventive & Translational Medicine for Geriatric Diseases, School of Public Health, Medical College of Soochow University, China

    ‡These authors contributed equally to this work

    Search for more papers by this author

    ,
    Ru Li

    Department of Epidemiology, Jiangsu Key Laboratory of Preventive & Translational Medicine for Geriatric Diseases, School of Public Health, Medical College of Soochow University, China

    ,
    Huan Zhang

    **Author for correspondence: Tel.: +86 512 6588 3227;

    E-mail Address: hzhang3@suda.edu.cn

    Department of Epidemiology, Jiangsu Key Laboratory of Preventive & Translational Medicine for Geriatric Diseases, School of Public Health, Medical College of Soochow University, China

    &
    Xingbo Mo

    *Author for correspondence:

    E-mail Address: xbmo@suda.edu.cn

    Department of Epidemiology, Jiangsu Key Laboratory of Preventive & Translational Medicine for Geriatric Diseases, School of Public Health, Medical College of Soochow University, China

    Center for Genetic Epidemiology & Genomics, School of Public Health, Medical College of Soochow University, China

    Published Online:https://doi.org/10.2217/pgs-2022-0041

    Introduction: Genome-wide association studies have identified approximately 1000 lipid-associated loci, but functional variants are less known. Materials & methods: The authors identified RNA modification-related single-nucleotide polymorphisms (RNAm-SNPs) in summary data from a genome-wide association study. By applying Mendelian randomization analysis, the authors identified gene expression levels involved in the regulation of RNAm-SNPs on low-density lipoprotein cholesterol (LDL-C) levels. Results: The authors identified 391 RNAm-SNPs that were significantly associated with LDL-C levels. RNAm-SNPs in NPC1L1, LDLR, APOB, MYLIP, LDLRAP1 and ABCA6 were identified. The RNAm-SNPs were associated with gene expression. The expression levels of 112 genes were associated with LDL-C levels, and some of them (e.g., APOB, SMARCA4 and SH2B3) were associated with coronary artery disease. Conclusion: This study identified many RNAm-SNPs in LDL-C loci and elucidated the relationship among the SNPs, gene expression and LDL-C.

    References

    • 1. Lewington S, Whitlock G, Clarke R et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 370(9602), 1829–1839 (2007).
    • 2. Luo J, Yang H, Song BL. Mechanisms and regulation of cholesterol homeostasis. Nat. Rev. Mol. Cell Biol. 21(4), 225–245 (2020).
    • 3. Libby P, Buring JE, Badimon L et al. Atherosclerosis. Nat. Rev. Dis. Primers 5(1), 56 (2019).
    • 4. Teslovich TM, Musunuru K, Smith AV et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466(7307), 707–713 (2010).
    • 5. Willer CJ, Schmidt EM, Sengupta S et al. Discovery and refinement of loci associated with lipid levels. Nat. Genet. 45(11), 1274–1283 (2013).
    • 6. Graham SE, Clarke SL, Wu KH et al. The power of genetic diversity in genome-wide association studies of lipids. Nature 600(7890), 675–679 (2021).
    • 7. Surakka I, Horikoshi M, Magi R et al. The impact of low-frequency and rare variants on lipid levels. Nat. Genet. 47(6), 589–597 (2015).
    • 8. Asselbergs FW, Guo Y, Van Iperen EP et al. Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. Am. J. Hum. Genet. 91(5), 823–838 (2012).
    • 9. Kim YJ, Go MJ, Hu C et al. Large-scale genome-wide association studies in East Asians identify new genetic loci influencing metabolic traits. Nat. Genet. 43(10), 990–995 (2011).
    • 10. Wu Y, Waite LL, Jackson AU et al. Trans-ethnic fine-mapping of lipid loci identifies population-specific signals and allelic heterogeneity that increases the trait variance explained. PLOS Genet. 9(3), e1003379 (2013).
    • 11. Lu X, Peloso GM, Liu DJ et al. Exome chip meta-analysis identifies novel loci and East Asian-specific coding variants that contribute to lipid levels and coronary artery disease. Nat. Genet. 49(12), 1722–1730 (2017).
    • 12. Lu X, Li J, Li H et al. Coding-sequence variants are associated with blood lipid levels in 14,473 Chinese. Hum. Mol. Genet. 25(18), 4107–4116 (2016).
    • 13. Sidore C, Busonero F, Maschio A et al. Genome sequencing elucidates Sardinian genetic architecture and augments association analyses for lipid and blood inflammatory markers. Nat. Genet. 47(11), 1272–1281 (2015).
    • 14. Mao F, Xiao L, Li X et al. RBP-Var: a database of functional variants involved in regulation mediated by RNA-binding proteins. Nucleic Acids Res. 44(D1), D154–D163 (2016).
    • 15. Wu X, Hurst LD. Determinants of the usage of splice-associated cis-motifs predict the distribution of human pathogenic SNPs. Mol. Biol. Evol. 33(2), 518–529 (2016).
    • 16. Ramaswami G, Deng P, Zhang R, Carbone MA, Mackay TF, Li JB. Genetic mapping uncovers cis-regulatory landscape of RNA editing. Nat. Commun. 6, 8194 (2015).
    • 17. Malbec L, Zhang T, Chen YS et al. Dynamic methylome of internal mRNA N(7)-methylguanosine and its regulatory role in translation. Cell Res. 29(11), 927–941 (2019).
    • 18. Meyer KD, Jaffrey SR. The dynamic epitranscriptome: n6-methyladenosine and gene expression control. Nat. Rev. Mol. Cell Biol. 15(5), 313–326 (2014).
    • 19. Wang X, Lu Z, Gomez A et al. N6-methyladenosine-dependent regulation of messenger RNA stability. Nature 505(7481), 117–120 (2014).
    • 20. Edupuganti RR, Geiger S, Lindeboom RGH et al. N(6)-methyladenosine (m(6)A) recruits and repels proteins to regulate mRNA homeostasis. Nat. Struct. Mol. Biol. 24(10), 870–878 (2017).
    • 21. Visvanathan A, Somasundaram K. mRNA traffic control reviewed: n6-methyladenosine (m(6) A) takes the driver's seat. Bio. Essays 40(1), 1700093 (2018).
    • 22. Zheng Y, Nie P, Peng D et al. m6AVar: a database of functional variants involved in m6A modification. Nucleic Acids Res. 46(D1), D139–D145 (2018).
    • 23. Mo X, Lei S, Zhang Y, Zhang H. Genome-wide enrichment of m(6)A-associated single-nucleotide polymorphisms in the lipid loci. Pharmacogenomics J. 19(4), 347–357 (2019).
    • 24. Nikpay M, Goel A, Won HH et al. A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease. Nat. Genet. 47(10), 1121–1130 (2015).
    • 25. Canela-Xandri O, Rawlik K, Tenesa A. An atlas of genetic associations in UK Biobank. Nat. Genet. 50(11), 1593–1599 (2018).
    • 26. Bycroft C, Freeman C, Petkova D et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562(7726), 203–209 (2018).
    • 27. Pickrell JK. Joint analysis of functional genomic data and genome-wide association studies of 18 human traits. Am. J. Hum. Genet. 94(4), 559–573 (2014).
    • 28. Ward LD, Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 40(Database issue), D930–D934 (2012).
    • 29. Battle A, Brown CD, Engelhardt BE, Montgomery SB. Genetic effects on gene expression across human tissues. Nature 550(7675), 204–213 (2017).
    • 30. Zhu Z, Zhang F, Hu H et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat. Genet. 48(5), 481–487 (2016).
    • 31. Li LJ, Fan YG, Leng RX, Pan HF, Ye DQ. Potential link between m(6)A modification and systemic lupus erythematosus. Mol. Immunol. 93, 55–63 (2018).
    • 32. Goldstein JL, Brown MS. The LDL receptor. Arterioscler. Thromb. Vasc. Biol. 29(4), 431–438 (2009).
    • 33. Stitziel NO, Won HH, Morrison AC et al. Inactivating mutations in NPC1L1 and protection from coronary heart disease. N. Engl. J. Med. 371(22), 2072–2082 (2014).
    • 34. Muntoni S, Pisciotta L, Bertolini S. Pharmacological treatment of a Sardinian patient affected by autosomal recessive hypercholesterolemia (ARH). J. Clin. Lipidol. 9(1), 103–106 (2015).
    • 35. Xu Z, Lv B, Qin Y, Zhang B. Emerging roles and mechanism of m6A methylation in cardiometabolic diseases. Cells 11(7), 1101 (2022).